Back
BioCryst Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
66
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$7.70
Seasonality Move:
3.63%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioCryst Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.47 | Buy |
| 20-day SMA: | 7.45 | Buy |
| 50-day SMA: | 7.19 | Buy |
| 200-day SMA: | 8.25 | Sell |
| 8-day EMA: | 7.51 | Buy |
| 20-day EMA: | 7.43 | Buy |
| 50-day EMA: | 7.39 | Buy |
| 200-day EMA: | 7.86 | Sell |
BioCryst Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 58.41 | Buy |
| Chaikin Money Flow: | 854416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.03 - 7.67) | Buy |
| Bollinger Bands (100): | (7.02 - 8.16) | Buy |
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals, Inc. Stock
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 7.70 while BCRX 8-day simple moving average is 7.47, which is a Buy signal.
-
The stock price of BCRX is 7.70 while BioCryst Pharmaceuticals, Inc. 20-day SMA is 7.45, which makes it a Buy.
-
BioCryst Pharmaceuticals, Inc. 50-day simple moving average is 7.19 while BCRX share price is 7.70, making it a Buy technically.
-
BCRX stock price is 7.70 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 8.25, creating a Sell signal.
BCRX Technical Analysis vs Fundamental Analysis
Buy
66
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. a Buy or a Sell?
-
BioCryst Pharmaceuticals, Inc. stock is rated a BuyThe current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $7.70. The Score for BCRX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
BioCryst Pharmaceuticals, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
7.70
Share Volume:
1.5M
BioCryst Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.31
52-Week Low:
6.00
Buy
66
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
BioCryst Pharmaceuticals, Inc. Share Price Forecast
-
What is the BioCryst Pharmaceuticals, Inc. stock price today?The BioCryst Pharmaceuticals, Inc. stock price is 7.70 USD today.
-
Will BCRX stock go up or go down?BioCryst Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioCryst Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals, Inc. is not overvalued.
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 7.70 while BCRX 8-day exponential moving average is 7.51, which is a Buy signal.
-
The stock price of BCRX is 7.70 while BioCryst Pharmaceuticals, Inc. 20-day EMA is 7.43, which makes it a Buy.
-
BioCryst Pharmaceuticals, Inc. 50-day exponential moving average is 7.39 while BCRX share price is 7.70, making it a Buy technically.
-
BCRX stock price is 7.70 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 7.86, creating a Sell signal.
Fundamental Analysis of BioCryst Pharmaceuticals, Inc.
Is BioCryst Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.05 per share.
Technical Analysis of BioCryst Pharmaceuticals, Inc.
Should I short BioCryst Pharmaceuticals, Inc. stock?
-
BCRX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting BioCryst Pharmaceuticals, Inc. is a Buy
-
BioCryst Pharmaceuticals, Inc. Relative Strength Index (RSI) is 58.41, which suggest BioCryst Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for BioCryst Pharmaceuticals, Inc. is (7.03 - 7.67), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for BioCryst Pharmaceuticals, Inc. is (7.02 - 8.16), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.